GALECTIN THERAPEUTICS INC Share Price Today: Live Updates & Key Insights
GALECTIN THERAPEUTICS INC share price today is $3.49, up 0.58%. The stock opened at $3.37 against the previous close of $3.45, with an intraday high of $3.6 and low of $3.34.
GALECTIN THERAPEUTICS INC Share Price Chart
GALECTIN THERAPEUTICS INC
GALECTIN THERAPEUTICS INC Share Price Performance
GALECTIN THERAPEUTICS INC Institutional Holdings
GALECTIN THERAPEUTICS INC Market Status
GALECTIN THERAPEUTICS INC Fundamentals
Market Cap 227.21 M
PB Ratio 207.6975
PE Ratio 0.0
Enterprise Value 354.31 M
Total Assets 19.53 M
Volume 313368
GALECTIN THERAPEUTICS INC Company Financials
About GALECTIN THERAPEUTICS INC & investment objective
Company Information Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic disease and cancer. The company's lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in a Phase 2 clinical study in MASH patients with advanced fibrosis and a second Phase 2b clinical trial in MASH patients with compensated cirrhosis and portal hypertension. It has a joint venture co-owned by SBH Sciences, Inc. to research and develop small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Organisation Biotechnology
Employees 9
Industry Biotechnology
CEO Mr. Joel Lewis CPA
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
GALECTIN THERAPEUTICS INC FAQs
What is the share price of GALECTIN THERAPEUTICS INC today?
The current share price of GALECTIN THERAPEUTICS INC is $3.49.
Can I buy GALECTIN THERAPEUTICS INC shares in India?
Yes, Indian investors can buy GALECTIN THERAPEUTICS INC shares by opening an international trading and demat account with Motilal Oswal.
How to buy GALECTIN THERAPEUTICS INC shares in India?
You can easily invest in GALECTIN THERAPEUTICS INC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy GALECTIN THERAPEUTICS INC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of GALECTIN THERAPEUTICS INC.
Can I buy fractional shares of GALECTIN THERAPEUTICS INC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of GALECTIN THERAPEUTICS INC?
GALECTIN THERAPEUTICS INC has a market cap of $227.21 M.
In which sector does GALECTIN THERAPEUTICS INC belong?
GALECTIN THERAPEUTICS INC operates in the Biotechnology sector.
What documents are required to invest in GALECTIN THERAPEUTICS INC stocks?
To invest, you typically need:
What is the PE and PB ratio of GALECTIN THERAPEUTICS INC?
The PE ratio of GALECTIN THERAPEUTICS INC is N/A and the PB ratio is 207.70.